US8999957, Table 2, Compound 55

ID: ALA3654530

Chembl Id: CHEMBL3654530

PubChem CID: 89509116

Max Phase: Preclinical

Molecular Formula: C25H25FN6O

Molecular Weight: 444.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CCCN(Cc5ncccc5F)C4)cc23)ccn1

Standard InChI:  InChI=1S/C25H25FN6O/c1-16-12-17(8-10-27-16)24-20-13-18(6-7-22(20)30-31-24)25(33)29-19-4-3-11-32(14-19)15-23-21(26)5-2-9-28-23/h2,5-10,12-13,19H,3-4,11,14-15H2,1H3,(H,29,33)(H,30,31)/t19-/m1/s1

Standard InChI Key:  APADOXMKQCWQGW-LJQANCHMSA-N

Associated Targets(non-human)

Mapk3 Mitogen-activated protein kinase 3 (111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 444.51Molecular Weight (Monoisotopic): 444.2074AlogP: 3.86#Rotatable Bonds: 5
Polar Surface Area: 86.80Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.21CX Basic pKa: 6.24CX LogP: 2.53CX LogD: 2.50
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.49Np Likeness Score: -1.76

References

1.  (2015)  Heterocyclic compounds as ERK inhibitors, 

Source

Source(1):